Background: Anaphylaxis, mediated by immunoglobulin E, may be clinical
ly indistinguishable but is mechanistically different than chemically
mediated anaphylactoid reactions induced by drugs such as morphine, cu
rare, and vancomycin. A test to distinguish anaphylactic from anaphyla
ctoid reactions would clarify therapeutic and medicolegal issues. Tryp
tase levels identify anaphylactic reactions but have not been evaluate
d in vivo during anaphylactoid reactions. A prospective, randomized, d
ouble-blinded, placebo-controlled trial of antihistamine chemoprophyla
xis for rapid vancomycin infusion was performed, and plasma tryptase w
as measured using a new immunoassay, Histamine release was established
by measurement of plasma histamine and the ability of prophylactic H-
1 and H-2 antagonists to prevent common histamine-associated side effe
cts. Tryptase levels were compared with histamine levels and clinical
symptoms. Methods: Before elective arthroplasty, 40 patients received
vancomycin infusion (1 g over 10 min) and pretreatment with either ant
ihistamines (1 mg/kg diphenhydramine and 4 mg/kg cimetidine) or placeb
o. Changes in tryptase (at peak histamine and 10 min after vancomycin
infusion), histamine levels, and histamine-mediated symptoms mere asse
ssed using Fisher's exact test, the Student's t test, or the paired t
test, as appropriate. Logistic regression models were used to quantify
the association of clinical symptoms with antihistamine treatment and
serum levels. Results: Plasma tryptase levels mere unchanged (99% CI,
-0.5 to 1.6) independent of increased histamine levels, antihistamine
pretreatment, clinical symptoms, or all of these. Histamine levels >1
ng/ml were significantly associated with hypotension, moderate-to-sev
ere rash, and stopped infusion. Antihistamine pretreatment significant
ly decreased the incidence and severity of the reactions. Conclusion:
Plasma tryptase levels were not significantly elevated in confirmed an
aphylactoid reactions, so they can be used to distinguish chemical fro
m Immunologic reactions.